BALYASNY ASSET MANAGEMENT L.P. - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 182 filers reported holding PTC THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.65 and the average weighting 0.1%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$4,429,160
+15.0%
91,436
-9.4%
0.01%0.0%
Q4 2022$3,852,574
-5.6%
100,932
-7.7%
0.01%
-15.4%
Q1 2022$4,082,000
+22.8%
109,402
+31.1%
0.01%
+18.2%
Q4 2021$3,323,000
-17.5%
83,422
-23.0%
0.01%
-35.3%
Q3 2021$4,030,000
-61.1%
108,292
-55.8%
0.02%
-65.3%
Q2 2021$10,349,000
+3926.8%
244,832
+4360.4%
0.05%
+2350.0%
Q3 2020$257,000
-33.4%
5,489
-27.8%
0.00%
-33.3%
Q2 2020$386,000
-87.7%
7,598
-91.8%
0.00%
-86.4%
Q3 2019$3,149,000
-22.3%
93,122
+3.4%
0.02%
-15.4%
Q2 2019$4,052,000
-32.2%
90,038
-43.3%
0.03%
-35.0%
Q1 2019$5,975,000
-81.9%
158,751
-77.3%
0.04%
-73.3%
Q3 2018$32,933,000
+92.3%
700,692
+38.0%
0.15%
+92.3%
Q2 2018$17,127,000
+179.4%
507,761
+124.1%
0.08%
+200.0%
Q1 2018$6,130,000
+1929.8%
226,533
+1400.2%
0.03%
+2500.0%
Q3 2017$302,000
-93.8%
15,100
-96.5%
0.00%
-96.4%
Q3 2016$4,861,000
-43.0%
426,274
+204.0%
0.03%
-59.4%
Q1 2015$8,532,000
-11.8%
140,218
-25.0%
0.07%
-22.5%
Q4 2014$9,676,000
+785.3%
186,895
+346.9%
0.09%
+641.7%
Q2 2014$1,093,00041,8200.01%
Other shareholders
PTC THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 7,235,196$162,140,7423.42%
Camber Capital Management LP 3,400,000$76,1942.51%
ARMISTICE CAPITAL, LLC 6,150,000$137,821,5002.11%
GREAT POINT PARTNERS LLC 500,000$11,205,0002.04%
COWEN AND COMPANY, LLC 799,511$17,917,0411.25%
GEORGE KAISER FAMILY FOUNDATION 45,816$6,491,2111.22%
SPHERA FUNDS MANAGEMENT LTD. 218,459$4,895,6660.89%
SECTORAL ASSET MANAGEMENT INC 187,016$4,191,0290.82%
Nebula Research & Development LLC 21,858$489,8380.26%
Phocas Financial Corp. 64,701$1,450,0000.21%
View complete list of PTC THERAPEUTICS INC shareholders